MYNZ
Mainz Biomed NV
NASDAQ · Healthcare · Medical - Diagnostics & Research · DE
$3.59
+0.84%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.48x
- Price / sales
- 21.02x
- Price / cash flow
- -1.03x
Enterprise value
- Enterprise value
- $12.5M
- EV / sales
- 23.22x
- EV / EBITDA
- -0.77x
- EV / EBIT
- -0.77x
- Market cap
- $11.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025